Reporting Manager
Alyeska Investment Group, L.P.
Symbol
CABA
Shares outstanding
96,185,738 shares
Disclosed Ownership
5,800,000 shares
Ownership
6%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 20:06:51 UTC
Date of event
30 Sep 2025
Previous filing
14 Aug 2025
Next filing
17 Feb 2026

Quoteable Key Fact

"Alyeska Investment Group, L.P. disclosed 6% ownership in CABALETTA BIO, INC. Common Stock, par value $0.00001 per share (CABA) on 30 Sep 2025."

Quick Takeaways

  • Alyeska Investment Group, L.P. filed SCHEDULE 13G/A for CABALETTA BIO, INC. Common Stock, par value $0.00001 per share (CABA).
  • Disclosed ownership: 6%.
  • Date of event: 30 Sep 2025.

What Changed

  • Previous schedule filing date: 14 Aug 2025.
  • Current filing was accepted on 14 Nov 2025, 20:06.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Alyeska Investment Group, L.P. 6% 5,800,000 0 5,800,000 Jason Bragg Jason Bragg | Chief Financial Officer
Alyeska Fund GP, LLC 6% 5,800,000 0 5,800,000 Jason Bragg Jason Bragg | Chief Financial Officer
Anand Parekh 6% 5,800,000 0 5,800,000 Anand Parekh Anand Parekh | Self